Status:
TERMINATED
The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
BVSM
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6-64 years
Phase:
PHASE4
Brief Summary
Inhalation treatment with mucolytics is one of the cornerstones of CF treatment for respiratory problems. The efficacy of inhalation treatment with recombinant DNAse and hypertonic saline is well est...
Eligibility Criteria
Inclusion
- Patients who can perform lung function tests and who can produce sputum (\> 5 years of age)
- (Fe)males between 6-64 years
Exclusion
- Patients on the waiting lists for lung transplant.
- Pregnancy or breast feeding
- Patients can not take part in another 'inhalation'trial for Cystic Fibrosis
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00996424
Start Date
January 1 2010
End Date
December 1 2010
Last Update
August 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000